3455 — Healthcare & Medical Investment Income Statement
0.000.00%
Last trade - 00:00
- ¥43bn
- ¥80bn
- ¥5bn
- 15
- 49
- 26
- 16
2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | 2023 July 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,310 | 4,037 | 4,131 | 4,452 | 5,071 |
Cost of Revenue | |||||
Gross Profit | 2,754 | 3,274 | 2,357 | 2,555 | 2,961 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,473 | 1,862 | 1,985 | 2,114 | 2,349 |
Operating Profit | 1,837 | 2,176 | 2,146 | 2,338 | 2,722 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,588 | 1,863 | 1,833 | 2,015 | 2,348 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,586 | 1,862 | 1,831 | 2,013 | 2,346 |
Net Income Before Extraordinary Items | |||||
Net Income | 1,586 | 1,862 | 1,831 | 2,013 | 2,346 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,586 | 1,862 | 1,831 | 2,013 | 2,346 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6,301 | 5,986 | 5,888 | 6,008 | 6,527 |
Dividends per Share | |||||
Special Dividends per Share |